Dimerization-dependent serine protease activity of FAM111A prevents replication fork stalling at topoisomerase 1 cleavage complexes.
Palani, S., Machida, Y., Alvey, J.R., Mishra, V., Welter, A.L., Cui, G., Bragantini, B., Botuyan, M.V., Cong, A.T.Q., Mer, G., Schellenberg, M.J., Machida, Y.J.(2024) Nat Commun 15: 2064-2064
- PubMed: 38453899 
- DOI: https://doi.org/10.1038/s41467-024-46207-w
- Primary Citation of Related Structures:  
8S9K, 8S9L - PubMed Abstract: 
FAM111A, a serine protease, plays roles in DNA replication and antiviral defense. Missense mutations in the catalytic domain cause hyper-autocleavage and are associated with genetic disorders with developmental defects. Despite the enzyme's biological significance, the molecular architecture of the FAM111A serine protease domain (SPD) is unknown. Here, we show that FAM111A is a dimerization-dependent protease containing a narrow, recessed active site that cleaves substrates with a chymotrypsin-like specificity. X-ray crystal structures and mutagenesis studies reveal that FAM111A dimerizes via the N-terminal helix within the SPD. This dimerization induces an activation cascade from the dimerization sensor loop to the oxyanion hole through disorder-to-order transitions. Dimerization is essential for proteolytic activity in vitro and for facilitating DNA replication at DNA-protein crosslink obstacles in cells, while it is dispensable for autocleavage. These findings underscore the role of dimerization in FAM111A's function and highlight the distinction in its dimerization dependency between substrate cleavage and autocleavage.
Organizational Affiliation: 
Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN, USA.